Continuous glucose monitors cut HbA1c in non-insulin-treated type 2 diabetes trial

A 26-week US trial found that adults with type 2 diabetes not using insulin achieved better blood sugar control and spent about five more hours a day in the recommended glucose range with Dexcom’s G7 device. Adults with type 2…













